Company already validated this in previous PR. Expected database lock in late September and top line results shortly there after. Given every clinical trial to this point has been positive, expect some outstanding results from the Phase III study(ies). When this is released, will quickly jump to .80s and potentially to a dollar range. Now if they can find a partner in the mean time to license with for manufacture, etc. will easily jump to 1.50 and beyond. Time will tell, but expect some large moves, in either direction coming very shortly.
News 
Market Data 
Discover 
AI
